CA1272686A - Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie - Google Patents

Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie

Info

Publication number
CA1272686A
CA1272686A CA000503851A CA503851A CA1272686A CA 1272686 A CA1272686 A CA 1272686A CA 000503851 A CA000503851 A CA 000503851A CA 503851 A CA503851 A CA 503851A CA 1272686 A CA1272686 A CA 1272686A
Authority
CA
Canada
Prior art keywords
composition according
anthracycline
neoplastic
treat
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000503851A
Other languages
English (en)
Inventor
Eric Forssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexstar Pharmaceuticals Inc
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Priority claimed from US07/112,073 external-priority patent/US4769250A/en
Application granted granted Critical
Publication of CA1272686A publication Critical patent/CA1272686A/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
CA000503851A 1985-10-15 1986-03-12 Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie Expired - Lifetime CA1272686A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78753585A 1985-10-15 1985-10-15
US787,535 1985-10-15
US07/112,073 US4769250A (en) 1985-10-15 1987-10-26 Antracycline antineoplastic agents encapsulated in phospholipid vesicle particles and methods for using same for tumor therapy
USC.I.P.112073 1987-10-26

Publications (1)

Publication Number Publication Date
CA1272686A true CA1272686A (fr) 1990-08-14

Family

ID=26809566

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000503851A Expired - Lifetime CA1272686A (fr) 1985-10-15 1986-03-12 Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie

Country Status (1)

Country Link
CA (1) CA1272686A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112972366B (zh) * 2021-01-29 2023-11-17 张传钊 一种可注射光热化疗增敏载药水凝胶及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112972366B (zh) * 2021-01-29 2023-11-17 张传钊 一种可注射光热化疗增敏载药水凝胶及其制备方法

Similar Documents

Publication Publication Date Title
US4769250A (en) Antracycline antineoplastic agents encapsulated in phospholipid vesicle particles and methods for using same for tumor therapy
JP4555569B2 (ja) 増強された血中安定性を有する脂質キャリア組成物
Harrington et al. Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development
US5741516A (en) Sphingosomes for enhanced drug delivery
Mayer et al. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice
US5213804A (en) Solid tumor treatment method and composition
US5543152A (en) Sphingosomes for enhanced drug delivery
Mayhew et al. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid
EP0191824B1 (fr) Encapsulement d'agents antineoplastiques dans des liposomes
AU684209B2 (en) Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
WO1985000751A1 (fr) Lipides vesiculaires prepares dans une monophase
EP0358719B1 (fr) Compositions de liposomes de derives d'anthracycline
EP1448165B1 (fr) Compositions a vecteurs lipidiques et procedes garantissant une meilleure retention medicamenteuse
US20030113369A1 (en) Liposomes with enhanced circulation time and method of treatment
US5328678A (en) Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy
US20120207821A1 (en) Liposomal formulation and use thereof
JP2870657B2 (ja) 多段階包括/負荷方法による親油性薬物を含有するリポソームの調製方法
CA1272686A (fr) Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie
US20010051183A1 (en) Liposomes with enhanced circulation time and method of treatment
Gregoriadis Liposomes as Carriers of Drugs Observations on Vesicle Fate after Injection and Its Control
CA2467060A1 (fr) Compositions a vecteurs lipidiques garantissant une meilleure retention medicamenteuse

Legal Events

Date Code Title Description
MKEX Expiry